RE:RE:RE:Top pick Vancouver, BC, December 16, 2019 – Photon Control Inc. (“Photon Control” or the “Company”) (TSX: PHO), a leading developer and supplier of optical measurement technologies to the global semiconductor industry, is pleased to announce an expansion of its addressable market with a new product launched by Union Medical Co. Ltd. (“Union Medical”), a major Korean manufacturer producing laser, electrosurgical and other aesthetic equipment.
The Company’s optical sensors and systems have been designed into Union Medical’s high-frequency hyperthermia cancer treatment medical device, Neo Thermos, which is used to treat tumors without affecting normal cells. Photon Control’s temperature sensor systems are used to monitor the patient’s temperature during the treatment, and its fiber optic technology is immune to the radio frequency (“RF”) generated from the device.
“We have taken our products to the medical industry as part of our growth strategy of increasing our addressable market,” said Nigel Hunton, Chief Executive Officer. “This expansion to the medical industry confirms our ability to leverage our technology in markets sharing similar characteristics to our core business. With a strong market position in the semiconductor industry, we plan to build on our existing technology and know-how to enter into near-adjacent markets.”
“Union Medical is pleased to work with Photon Control on its Neo Thermos medical device,” said Bong-Suek Kim, Chief Technology Officer. “Neo Thermos is an exciting innovative device for cancer treatment without affecting normal cells. Photon Control has a proven solution in the semiconductor industry for a number of years, and we are pleased with the high levels of accuracy, reliability and repeatability of their temperature sensors and systems.”